BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31805812)

  • 1. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
    Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
    Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of arteriovenous malformations in the absence of endoglin.
    Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
    Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.
    Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L
    Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
    Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial endoglin does not protect against arteriovenous malformations.
    Singh E; Redgrave RE; Phillips HM; Arthur HM
    Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
    Sugden WW; Siekmann AF
    Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.
    Han C; Choe SW; Kim YH; Acharya AP; Keselowsky BG; Sorg BS; Lee YJ; Oh SP
    Angiogenesis; 2014 Oct; 17(4):823-830. PubMed ID: 24957885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
    Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
    Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression.
    Tual-Chalot S; Mahmoud M; Allinson KR; Redgrave RE; Zhai Z; Oh SP; Fruttiger M; Arthur HM
    PLoS One; 2014; 9(6):e98646. PubMed ID: 24896812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired SMAD1/5 Mechanotransduction and Cx37 (Connexin37) Expression Enable Pathological Vessel Enlargement and Shunting.
    Peacock HM; Tabibian A; Criem N; Caolo V; Hamard L; Deryckere A; Haefliger JA; Kwak BR; Zwijsen A; Jones EAV
    Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):e87-e104. PubMed ID: 32078368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced angiogenic responses in adult Endoglin heterozygous mice.
    Jerkic M; Rodríguez-Barbero A; Prieto M; Toporsian M; Pericacho M; Rivas-Elena JV; Obreo J; Wang A; Pérez-Barriocanal F; Arévalo M; Bernabéu C; Letarte M; López-Novoa JM
    Cardiovasc Res; 2006 Mar; 69(4):845-54. PubMed ID: 16405930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
    Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
    Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
    Choi EJ; Chen W; Jun K; Arthur HM; Young WL; Su H
    PLoS One; 2014; 9(2):e88511. PubMed ID: 24520391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.
    Arthur HM; Roman BL
    Front Med (Lausanne); 2022; 9():973964. PubMed ID: 36250069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.